WAM
ALXA

Wolverine Asset Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Wolverine Asset Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-17
Closed -$1K – 3006
2013
Q4 		$1K Hold
17
– – ﹤0.01% 2642
2013
Q3 		$2K Hold
17
– – ﹤0.01% 2558
2013
Q2 		$1K Buy
+17
New +$77 ﹤0.01% 2626

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wolverine Asset Management's ALXA Position: Q4 2013 in Review

Wolverine Asset Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2013, closing a stake of 5,300 shares — an estimated $26K sold.

Wolverine Asset Management first reported a position in ALXA in Q2 2013 and held it in 2 quarters. The position peaked at $27K in Q3 2013. 41 funds tracked by Wall St. Rank hold ALXA as of Q4 2013.

  • Wolverine Asset Management reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Wolverine Asset Management sold 5,300 Alexza Pharmaceuticals Inc shares in Q4 2013, an estimated $26K.
  • Wolverine Asset Management first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Wolverine Asset Management's Alexza Pharmaceuticals Inc position peaked at $27K in Q3 2013.
  • 41 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2013.

Based on Wolverine Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.